Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
Open Access
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 5 (5) , e12566
Abstract
No abstract availableKeywords
Funding Information
- Daiichi-Sankyo
This publication has 20 references indexed in Scilit:
- An overview of the most commonly used venous quality of life and clinical outcome measurementsJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2015
- Quality of life after pulmonary embolism: Prospective validation of the German version of the PEmb-QoL questionnaireThrombosis Research, 2015
- Quality of life after pulmonary embolism: validation of the French version of the PEmb-QoL questionnaireHealth and Quality of Life Outcomes, 2014
- The post-PE syndrome: a new concept for chronic complications of pulmonary embolismBlood Reviews, 2014
- Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoLThrombosis Research, 2013
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous ThromboembolismNew England Journal of Medicine, 2013
- Quality of Life in Long-term Survivors of Acute Pulmonary EmbolismChest, 2010
- Quality of life after pulmonary embolism: validation of the PEmb‐QoL QuestionnaireJournal of Thrombosis and Haemostasis, 2010
- Persistent dyspnea complaints at long-term follow-up after an episode of acute pulmonary embolism: Results of a questionnaireEuropean Journal of Internal Medicine, 2008
- Relation between quality of anticoagulant treatment and the development of the postthrombotic syndromeJournal of Thrombosis and Haemostasis, 2005